Skip to main content

Spotlight On Myeloproliferative Neoplasms (MPNs)

November 2, 2022

We invite you to learn more about:

  • The different types of Myeloproliferative Neoplasms (MPNs)
  • Therapies for MPNs
  • Current research and clinical trials for MPNs
  • Managing side effects

Aaron T. Gerds, MD, MS
Associate Professor of Medicine, Hematology & Medical Oncology
Deputy Director for Clinical Research
Cleveland Clinic Taussig Cancer Institute
Medical Director
Case Comprehensive Cancer Center Clinical Research Office
Cleveland, OH

Program Support

This program is supported by Bristol Myers Squibb and Incyte.

See All Resources

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.